Steven M. Horwitz

ORCID: 0000-0002-6399-2006

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 45 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3706

N/A

4.4DataRank · unranked

198 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Blood(2021)10.1182/blood.2020010387

N/A

3.4DataRank · unranked

126 citations

Tetiana Skrypets, Monica Civallero, Michael A. Spinner, Martina Manni, Won-Seog Kim +14 more

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00103-4

N/A

2.5DataRank · unranked

86 citations

Graham P. Collins, Paolo F. Caimi, Felipe Samaniego, Alexander I. Spira, Andrew Davies +13 more

Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma

Blood(2023)10.1182/blood.2022018254

N/A

1.3DataRank · unranked

46 citations

Alison J. Moskowitz, Neha Mehta–Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov +19 more

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Blood Advances(2022)10.1182/bloodadvances.2020003971

N/A

1.1DataRank · unranked

40 citations

Steven M. Horwitz, Ranjana H. Advani, Jacob Haaber Christensen, Eva Domingo‐Doménech, Giuseppe Rossi +19 more

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2183

N/A

0.850DataRank · unranked

22 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

Blood Cancer Journal(2025)10.1038/s41408-025-01329-2

N/A

0.282DataRank · unranked

5 citations

Barbara Pro, Tim Illidge, Steven M. Horwitz, Lorenz Truemper, Swaminathan P. Iyer +22 more

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014263

N/A

0.113DataRank · unranked

1 citations

Parastoo B. Dahi, Farhad Khimani, Andrei R. Shustov, Mazyar Shadman, Jia Ruan +19 more

2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL

Aesthetic Surgery Journal(2022)10.1093/asj/sjac133

N/A

0DataRank · unranked

67 citations

Mark W. Clemens, Michaël Atlan, Giovanni Botti, Peter G. Cordeiro, Daphne de Jong +14 more

Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?

Aesthetic Surgery Journal(2022)10.1093/asj/sjac305

N/A

0DataRank · unranked

5 citations

Mark W. Clemens, Michaël Atlan, Giovanni Botti, Peter G. Cordeiro, Daphne de Jong +15 more

Alliance A059102: A randomized phase II U.S. intergroup study of CHO(E)P versus CC-486-CHO(E)P versus duvelisib-CHO(E)P in previously untreated, CD30-negative, peripheral T-cell lymphomas.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7593

N/A

0DataRank · unranked

4 citations

Susan M. Geyer, Stefan K. Barta, Jennifer E. Amengual, Travis Dockter, Chadwick Wright +8 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Low incidence of cardiotoxicity in patients with non‐Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure

European Journal Of Haematology(2023)10.1111/ejh.13971

N/A

0DataRank · unranked

1 citations

Esther Drill, Steven M. Horwitz, Andréa LeVoir, Terry Pak, Tim Peterson +3 more

Data from Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

(2023)10.1158/1078-0432.c.6530889.v1

N/A

0DataRank · unranked

0 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023011733

N/A

0DataRank · unranked

10 citations

Rohan Sardana, David Nemirovsky, Denise Frosina, Achim A. Jungbluth, W. Thomas Johnson +7 more

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054

N/A

0DataRank · unranked

9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas

Haematologica(2024)10.3324/haematol.2024.285183

N/A

0DataRank · unranked

3 citations

Kseniya Petrova‐Drus, Rohan Sardana, Sarah Huet, Qi Gao, Shenon Sethi +9 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800

N/A

0DataRank · unranked

4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Failing Forward in Peripheral T-Cell Lymphoma

Journal of Clinical Oncology(2024)10.1200/jco.23.02658

N/A

0DataRank · unranked

3 citations

Steven M. Horwitz, Neha Mehta–Shah

Ibrutinib-associated osteonecrosis of the jaw

Oral Oncology Reports(2024)10.1016/j.oor.2024.100228

N/A

0DataRank · unranked

2 citations

Sion Na, Joseph M. Huryn, Cherry L. Estilo, Steven M. Horwitz, SaeHee K. Yom +1 more

Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience

Cytometry Part B Clinical Cytometry(2024)10.1002/cyto.b.22162

N/A

0DataRank · unranked

2 citations

Romany Auclair, Qi Gao, Paola Ghione, Steven M. Horwitz, Ahmet Doǧan +3 more

BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation

American Journal of Hematology(2024)10.1002/ajh.27291

N/A

0DataRank · unranked

1 citations

Agrima Mian, Samantha Brown, Sean M. Devlin, Paolo F. Caimi, Stephanie Chinapen +14 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell Malignancy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.03.587917

N/A

0DataRank · unranked

0 citations

Andrew Cornish, H. Mytrang, Julia S. Brunner, Ting-Wei Hsu, Zijian Xu +10 more

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

New England Journal of Medicine(2025)10.1056/nejmoa2411507

N/A

0DataRank · unranked

86 citations

Nayan Jain, Michael Scordo, Ruchi Patel, Özgür Can Eren, Utsav Patel +21 more

New treatments for adult T-cell leukemia/lymphoma

Leukemia Research(2025)10.1016/j.leukres.2025.107642

N/A

0DataRank · unranked

7 citations

Ashwath Gurumurthi, Steven M. Horwitz, Zachary D. Epstein‐Peterson

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma

American Journal of Hematology(2025)10.1002/ajh.27736

N/A

0DataRank · unranked

6 citations

Weiwei Zhang, Sunandini Sharma, Harald Holte, Roshani Shah, Waseem Lone +39 more

Dermatologic Adverse Events in Patients Receiving Duvelisib Single-Agent and Combination Therapies

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.07.011

N/A

0DataRank · unranked

2 citations

Nivetha Ganesan, Stephen W. Dusza, Steven M. Horwitz, Alison J. Moskowitz, Shamir Geller +1 more

Temporal clonal relatedness between myeloid neoplasm and nodal T-follicular helper cell lymphoma: a retrospective study

Blood Neoplasia(2025)10.1016/j.bneo.2025.100112

N/A

0DataRank · unranked

1 citations

Robert Stuver, Kai Shiang Lin, W. Thomas Johnson, Steven M. Horwitz, Ahmet Doǧan +2 more

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Blood Cancer Journal(2020)10.1038/s41408-020-00340-z

N/A

0DataRank · unranked

203 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas

Haematologica(2025)10.3324/haematol.2025.288615

N/A

0DataRank · unranked

1 citations

Mingfei Yan, Nivetha Ganesan, Tiffany Chang, Ahmet Doǧan, Zachary D. Epstein‐Peterson +11 more

Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants

Journal of Plastic Reconstructive & Aesthetic Surgery(2020)10.1016/j.bjps.2019.11.064

N/A

0DataRank · unranked

185 citations

Paola Ghione, Ai Ni, Qunying Hu, Nivetha Ganesan, Natasha Galasso +3 more

Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms

Blood Advances(2020)10.1182/bloodadvances.2020001636

N/A

0DataRank · unranked

111 citations

Kseniya Petrova‐Drus, Sarah Huet, Zachary D. Epstein‐Peterson, Qi Gao, Allison E. Sigler +12 more

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002396

N/A

0DataRank · unranked

96 citations

Promie Faruque, Neha Mehta–Shah, Venkatraman Seshan, Neval Özkaya, Shakthi Bhaskar +15 more

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma

Blood Cancer Journal(2020)10.1038/s41408-020-0301-x

N/A

0DataRank · unranked

18 citations

Qi Gao, Neval Özkaya, Sarah Huet, Natasha Lewis, Janine Pichardo +5 more

A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries

Cancers(2020)10.3390/cancers12061603

N/A

0DataRank · unranked

18 citations

Luca Vincenzo Cappelli, Paul Zumbo, Jude M. Phillip, Zhaoqi Liu, Shuhua Cheng +17 more

Oncologic Immunomodulatory Agents in Patients with Cancer and COVID-19

medRxiv(2020)10.1101/2020.08.11.20145458

N/A

0DataRank · unranked

2 citations

Aaron J. Stonestrom, Sean M. Devlin, Teresa Nguyentran, Beatriz Wills, Varun Narendra +10 more

The Genetic Basis of Hepatosplenic T-cell Lymphoma

UNC Libraries(2020)10.17615/vdkf-4m21

N/A

0DataRank · unranked

0 citations

Wing C. Chan, Steven M. Horwitz, Eric D. Hsi, Anupama Reddy, Nicholas S. Davis +50 more

Oncologic immunomodulatory agents in patients with cancer and COVID-19

Scientific Reports(2021)10.1038/s41598-021-84137-5

N/A

0DataRank · unranked

14 citations

Aaron J. Stonestrom, Sean M. Devlin, Teresa Nguyentran, Beatriz Wills, Varun Narendra +10 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

0DataRank · unranked

1528 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more